Vanderbilt Vaccine (VV) CRS [Site ID: 30352] — Nashville, Tennessee

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] is a clinical research site located in Nashville, Tennessee, United States 37232-2582.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hiv.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Vaccine (VV) CRS [Site ID: 30352]?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Vaccine (VV) CRS [Site ID: 30352] conducted?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has 1 clinical trials on record, with 1 currently active. Their work covers Hiv.

Is Vanderbilt Vaccine (VV) CRS [Site ID: 30352] accredited by Crixeo Health?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Vaccine (VV) CRS [Site ID: 30352]?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.